Written and maintained by CASRAI Editorial Board
Last updated
Electroporation delivers nucleic acids, proteins, or small molecules into cells by applying a brief, strong electric field that transiently destabilizes the plasma membrane, opening pores large enough for macromolecules to cross. It is the physical-delivery workhorse for cells that resist lipid-based transfection — primary cells, suspension lines, stem cells, and immune cells — and it is also how most electrocompetent bacteria are transformed. Getting it right is less about finding a single “correct” setting than about understanding the trade-off it always involves: enough field strength to open pores and deliver cargo, not so much that the cell cannot reseal and survive. This guide covers the mechanism, the parameters you actually control, buffer chemistry, and why the same nominal protocol behaves very differently across cell types.
For the broader question of which delivery method to use at all — chemical, physical, or viral — see Transfection: Choosing a Method, Optimising It, and the Biosafety Approval You Need. That guide compares electroporation against lipofection, nucleofection, and viral transduction at a method-selection level. This page assumes you have already chosen electroporation and goes deep on the parameters, buffers, and cell-type adjustments that determine whether it works.
How electroporation works
Cells are suspended in a conductive or semi-conductive buffer between two electrodes — typically the aluminum plates of a disposable cuvette — and subjected to a short, high-voltage electrical pulse. The applied field induces a transmembrane potential across the lipid bilayer; once that potential exceeds a cell-type-specific threshold (roughly 0.2-1 V across the membrane, depending on cell size and composition), the bilayer’s structure is disrupted and aqueous pores form. While the field is on and briefly afterward, these pores allow charged macromolecules — DNA, RNA, proteins — to move across the membrane, driven partly by electrophoretic force during the pulse itself and partly by simple diffusion afterward. The membrane then reseals, generally within seconds to a few minutes, as the cell’s own repair processes restore bilayer integrity. Whether the cell survives that resealing process — and whether the cargo made it in — is what every parameter below is trying to control.
The same physics that delivers cargo can also kill the cell: too large a fraction of the membrane destabilized, too long before resealing, or too much associated heating and ionic disruption pushes the cell into necrosis or apoptosis instead of simply taking up material. Electroporation optimization is fundamentally about finding the field strength and duration that maximizes the population of cells that are permeabilized and reseal successfully, for a specific cell type in a specific buffer.
Key pulse parameters
Instruments vary in how they let you set these, but the underlying variables are the same regardless of manufacturer:
- Voltage / field strength. What matters biophysically is field strength (voltage divided by the gap between electrodes, typically expressed in V/cm for a standard cuvette), not voltage alone — the same voltage in a 1 mm-gap cuvette produces a much stronger field than in a 4 mm-gap cuvette. Field strength requirements scale inversely with cell diameter: larger cells (many mammalian cell lines) need lower field strengths than smaller cells (bacteria, yeast), because a larger cell accumulates more transmembrane potential for the same external field.
- Pulse length (duration). Longer pulses deliver more total energy and drive more cargo across the membrane per pulse, but also increase the fraction of cells that fail to reseal. Mammalian cell protocols commonly use pulses on the order of tens of microseconds to a few milliseconds; bacterial electroporation typically uses much shorter, higher-field pulses. Reducing temperature (working on ice or at 4°C) generally allows shorter effective pulses for a comparable delivery outcome, because membrane fluidity and repair kinetics both slow down.
- Pulse number. Some protocols use a single pulse; others use multiple shorter pulses (sometimes at different voltages — a higher-voltage “poring” pulse followed by lower-voltage “transfer” pulses is a common two-stage design). Multiple pulses can improve delivery without raising peak field strength as high as a single-pulse approach would need, at the cost of cumulative stress on the cell.
- Waveform: exponential-decay vs. square-wave. Older and simpler systems discharge a charged capacitor through the sample, producing an exponential-decay pulse — high peak voltage that decays over milliseconds, governed by the system’s capacitance and the sample’s resistance (a function of buffer conductivity and cuvette geometry). Capacitance is the parameter you set; the actual pulse shape delivered depends on it interacting with your sample’s resistance, which is why the same capacitance setting behaves differently in high- versus low-conductivity buffer. Square-wave systems instead hold a constant voltage for a defined duration regardless of sample resistance, which gives more reproducible, cell-type-independent control and is generally gentler on sensitive cells — most modern instruments for mammalian and primary-cell work use square-wave pulses for this reason.
Every one of these interacts with the others and with the buffer (below) — changing buffer conductivity changes the effective field an exponential-decay system delivers even at a fixed capacitance setting. Optimization is a joint search over parameters and buffer, not a single dial. Because starting points genuinely differ by instrument, cuvette gap, and cell type, this guide describes the principles rather than prescribing specific voltage/capacitance figures for any named commercial system — consult your instrument’s cell-type-specific protocol library or the primary literature for your exact cell line as a starting point, then optimize from there.
Buffer chemistry
The buffer is not a passive vehicle — its ionic composition and conductivity directly shape the pulse the cell actually experiences.
- Conductivity. High-conductivity buffers (like simple physiological saline or standard PBS) carry more current for a given voltage, which increases Joule heating and the risk of arcing — a visible spark and audible pop in the cuvette that usually means the sample overheated locally and cell death will be high in that population. Lower-conductivity, specially formulated electroporation buffers reduce current flow at a given voltage, which lets you apply higher field strengths with less heating, and — counterintuitively — tends to produce larger, more effective pores at a given voltage than the same voltage in a highly conductive medium.
- Ionic composition matched to the cytosol. Purpose-made electroporation buffers are formulated to approximate intracellular ionic composition (higher potassium, lower sodium than extracellular fluid) rather than standard extracellular saline. The rationale is to minimize the disruption to the cell’s Na+/K+ gradient during the window when the membrane is porous — a large, sudden Na+/K+ exchange across an open pore is itself a stressor that lowers viability independent of the electrical pulse.
- Osmolarity. Some optimized buffers are deliberately hypo-osmolar, causing cells to swell and round up slightly before pulsing. A more spherical, slightly swollen cell presents a more uniform, predictable membrane geometry to the field, which improves pore formation consistency across the population compared to cells in their normal, more irregular adherent or stellate morphology.
- Simple saline / PBS as a buffer. It works, and is standard for some bacterial and yeast protocols (often after extensive washing to remove salts entirely, since electrocompetent bacterial preparations are typically pulsed in very low-conductivity water or glycerol solutions specifically to avoid arcing at the high field strengths bacterial electroporation requires). For mammalian and especially primary cells, plain saline or serum-containing culture medium is usually a poor choice — high conductivity, wrong ionic ratios, and (for culture medium) phenol red and other components that don’t meaningfully help and can worsen outcomes.
Cell-type-specific optimization
The same nominal “electroporation protocol” looks very different depending on what you’re pulsing, which is why generic instructions transfer poorly between cell types:
- Bacteria. Electrocompetent bacterial cells are small, have a cell wall in addition to the membrane, and are pulsed in extremely low-conductivity solutions (water or glycerol, salt-free) at high field strengths and very short pulse durations — arcing is the dominant failure mode here because residual salt from an incompletely washed prep raises conductivity sharply. Time constant, not absolute voltage, is often the reported optimization target for bacterial systems.
- Mammalian cell lines (adherent and suspension). Established, robust lines (many immortalized lines used routinely in cell culture) tolerate a wider parameter window and are the easiest starting point for a lab establishing a new protocol. Suspension lines are generally more electroporation-friendly than adherent lines, which typically need to be trypsinized and resuspended immediately before pulsing — the trypsinization step itself is a variable, since incomplete recovery from it compounds electroporation stress.
- Primary cells. Primary cells (freshly isolated, not immortalized) are usually far more sensitive: more fragile membranes, limited proliferative reserve to recover from stress, and much less tolerance for parameters that a robust cell line would shrug off. Protocols validated on a cell line essentially never transfer directly to the equivalent primary cell type; primary-cell electroporation almost always needs its own optimization pass, generally starting from a lower field strength and shorter pulse than the cell-line equivalent and titrating up while watching viability, not just delivery efficiency.
- Stem cells and immune cells. Both are common electroporation targets specifically because they transfect poorly by lipid-based methods, and both are notably sensitive to electrical and mechanical stress — cell state (passage number, activation state for immune cells, confluency) measurably affects outcome and is a common source of day-to-day variability that looks like “the protocol stopped working” when nothing about the electrical parameters actually changed.
Common failure modes
| Symptom | Likely cause | What to check first |
|---|---|---|
| Massive cell death, little or no surviving population | Over-electroporation — field strength, pulse length, or pulse number too high for this cell type; often compounded by high-conductivity buffer | Reduce voltage/field strength and re-titrate; confirm you’re using a low-conductivity buffer suited to the cell type, not saline or full culture medium |
| Visible arcing / popping sound during the pulse | Buffer conductivity too high for the field strength applied — often residual salt in an incompletely washed bacterial prep, or plain saline used for mammalian cells | Discard that sample (it is not representative of a clean pulse); re-check buffer conductivity and washing/dialysis steps before re-pulsing |
| Cells survive well but little or no cargo delivered (low efficiency) | Under-electroporation — field strength or pulse duration too low to reliably open pores for this cell type | Increase field strength or pulse length incrementally rather than jumping to a much higher setting; confirm cargo (DNA/RNA) concentration and purity are adequate — a clean pulse with insufficient or degraded cargo also looks like “low efficiency” |
| Efficiency and viability both inconsistent run to run with unchanged settings | Cell-state variability (passage number, confluency, activation state, time since thaw) rather than an electrical-parameter problem | Standardize cell prep (density, passage window, recovery time post-thaw) before troubleshooting the pulse parameters further |
| Good delivery, but transgene expression is delayed or transient rather than sustained | Expected for electroporation of naked plasmid/RNA into cells without an integrating mechanism — this is a property of the cargo/method, not a pulse-parameter failure | If sustained/stable expression is the actual goal, electroporation of a naked plasmid is the wrong tool; consider a selection strategy, an integrating cargo design, or viral transduction instead |
Electroporation vs. other delivery methods — when this is the right tool
Electroporation is not the default choice for every application. It reliably outperforms lipid-based chemical methods for cells that resist lipofection (primary cells, suspension lines, stem cells, immune cells) and is far simpler to set up than viral transduction, with none of the biosafety/IBC overhead that lentiviral or AAV work carries. Its costs are a dedicated instrument, consumable cuvettes/buffers, and — almost always — a real viability hit relative to a well-optimized chemical method on an easy-to-transfect line. If you have not yet decided which delivery method to use at all, Transfection: Choosing a Method, Optimising It, and the Biosafety Approval You Need walks through the full decision, including when viral transduction is the better answer for stable, integrated expression. This page is the deep dive once electroporation is the chosen method.
Frequently asked questions
What voltage should I use for electroporation?
There is no single correct voltage — the right setting depends on cell diameter, cuvette gap, buffer conductivity, and instrument waveform (exponential-decay vs. square-wave). Start from a published, cell-type-specific protocol close to your actual cell type as a baseline, then titrate: run a small viability/efficiency optimization series around that starting point rather than assuming a number that worked for a different cell type or instrument will transfer directly.
Why did most or all of my cells die after electroporation?
This is almost always over-electroporation: field strength, pulse duration, or pulse number too high for the cell type, frequently made worse by a buffer with higher conductivity than the protocol calls for. Visible arcing during the pulse is a strong signal of exactly this. Reduce the field strength and re-titrate rather than assuming the method itself is unsuitable for your cells.
What’s the difference between electroporation and nucleofection?
Nucleofection is a proprietary variant of electroporation that pairs cell-type-specific pulse programs with proprietary buffer formulations, marketed specifically for delivery to the nucleus and for hard-to-transfect cells like primary and stem cells. Mechanistically it is still electroporation — a pulsed electric field transiently permeabilizing the membrane — the differentiation is in the pre-optimized program/buffer pairings rather than a different underlying physical principle.
Can I use PBS or plain saline as electroporation buffer?
You can, and it is standard for some bacterial/yeast protocols after thorough desalting, but for mammalian and especially primary cells it is usually a poor choice: PBS and saline are relatively high-conductivity and don’t match intracellular ionic composition, which tends to produce more heating, more arcing risk, and lower viability than a buffer formulated for electroporation. If viability is a problem, buffer composition is one of the first things to check, not just voltage.
Does a protocol that works on a cell line also work on the matching primary cell type?
Not reliably. Primary cells are generally more fragile, have less capacity to recover from stress, and often need lower field strength and shorter pulses than the immortalized-line equivalent. Treat a cell-line-validated protocol as a starting reference point for primary-cell work, not a protocol you can use unmodified.
See also Cell Culture Basics: A Beginner’s Guide for New Lab Members and Cryopreservation of Cells: Basic Protocol and Best Practices for adjacent bench fundamentals.
